Related Experiment Videos
Inhibition of adenylate cyclase by tetraplatin
1Department of Neuro-oncology, University of Texas MD Anderson Cancer Center 77030.
Anti-Cancer Drugs
|June 1, 1991
Abstract:
In the investigation of effects of platinum-containing compounds on dopamine (DA)-activated adenylate cyclase system, tetraplatin and cisplatin were found to suppress the increase of enzyme activity by various activators. However, tetraplatin was a much more potent inhibitor than cisplatin, with its I50 values being 1/25, 1/45, and 1/130 that of cisplatin in the presence of DA/Gpp(NH)p, NaF/AlCl3, and forskolin/Gpp(NH)p respectively.